Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma

Completed · Phase 3

Conditions studied: Lymphoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Giving the drugs in different doses may kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy with various combinations of drugs in treating pediatric patients with advanced-stage large cell lymphoma.

Key facts

Study ID

NCT00002618

Run by

Children's Oncology Group

People needed

242

Starts

1994-12-01

Expected to finish

2006-09-01

Last updated by the study team

2014-07-24

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Via Christi Regional Medical Center-Saint Francis Campus — Wichita, Kansas, United States
• MBCCOP - LSU Medical Center — New Orleans, Louisiana, United States
• Memorial Mission Hospital — Asheville, North Carolina, United States
• Medical University of South Carolina — Charleston, South Carolina, United States
• Medical City Dallas Hospital — Dallas, Texas, United States
• San Antonio Military Pediatric Cancer and Blood Disorders Center — Lackland Air Force Base, Texas, United States
• University of Texas Health Science Center at San Antonio — San Antonio, Texas, United States
• Cancer Center, University of Virginia HSC — Charlottesville, Virginia, United States
• University of Puerto Rico School of Medicine Medical Sciences Campus — San Juan, Puerto Rico
• Clinique de Pediatrie — Geneva, Switzerland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.